Department of Clinical Pharmacology, Medical University of Vienna
Vienna, Austria
NCT Number: NCT07818239
In a typical clinical setting, patient eating habits are not controlled when performing optical coherence tomography (OCT) imaging for retinal diagnostics. Nevertheless, the timing of the patient's most recent meal has the potential to impact OCT metrics particularly for those involving blood vessels, such as vascular density. Studies have shown that eating a high fat meal can increase blood fat levels in the hours following the meal. In particular, chylomicrons, the fat particles that will most likely affect the OCT signal, peak in concentration about 2-3 hours after eating. Preclinical animal studies have shown that intravascular injections of fat emulsions in rodent models can cause an increase in OCT signal and make blood vessels more visible. This study investigates the impact of a single high fat meal on OCT and OCT angiography (OCTA) measurements of retinal vessels and whether these effects differ from the effects of a single low-fat, high carbohydrate meal.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Vienna, Austria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Consumption of a high fat meal: Volume 500ml, Lipid 80 % of calories
Consumption of a high carbohydrate meal: Volume 500ml, Carbohydrate 80% of calories
Time frame: On both study days, from the start of the meal consumption every 30 min up to 5 hours after meal consumption; BL, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 270min, 300min
Retinal vessel area density measured by OCTA
Interested in participating?
Request InfoMedical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07692815
Female, Healthy Adult
Louvain-la-Neuve, Belgium
View Trial DetailsNCT06726018
Healthy Adult, Neurologic Manifestations
El Paso, Texas, United States
View Trial DetailsNCT07604740
Healthy Adult
Helsinki, Finland
View Trial DetailsNCT07490483
Between 20-25 Years Old, Healthy Adult
Cairo, Egypt
View Trial Details